When the Stock Market Overreacts
The Alzheimer's fantasy is gone – the obesity revolution remains!
The market is playing doomsday, I see a buying opportunity!
Reading Time: 2 minutes
The stock market sometimes overreacts in both directions. With Novo Nordisk, we are currently witnessing the negative variant: the Semaglutide medication does not work against Alzheimer's, the EVOKE studies have failed, and the little remaining hope for a new "wonder indication" has been dashed. However, this does not change the fact that we still have an extremely effective diabetes and weight loss drug – just without any additional magic in Alzheimer's therapy. Many had warned beforehand that the stock could plummet massively if this tiny chance...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
